Related Experiment Video

Updated: Jul 14, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Human erythroleukemia: is the two-hit model of mouse leukemogenesis valid in human disease?

S Coulon, J Vandekerckhove, M Dussiot

    Leukemia
    |June 2, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
    08:00

    A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

    Published on: October 14, 2016

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
    08:00

    A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

    Published on: October 14, 2016

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    Related Concept Videos

    Mouse Models of Cancer Study02:43

    Mouse Models of Cancer Study

    Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
    The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

    Articles linked to this work by shared authors, journal, and citation graph.

    Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country.

    Bone marrow transplantation·2026

    The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification.

    ESMO real world data and digital oncology·2026

    Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025

    Determinants of radiological patterns and severity in immunocompromised adults with Metapneumovirus infection.

    Respiratory medicine·2024

    [Pulmonary complications of Chronic Granulomatous Disease].

    Revue des maladies respiratoires·2024

    Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

    Nature medicine·2022

    Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

    Leukemia·2026

    Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.

    Leukemia·2026

    Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

    Leukemia·2026

    Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy.

    Leukemia·2026

    KLF4/MLL3 complex axis drives NRBP2 transcription to eliminate acute myeloid leukemia cells.

    Leukemia·2026

    Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

    Leukemia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us